UMIN-CTR Clinical Trial

Basic information
Official scientific title of the study	Pancreatic cancer project in Matsue
Title of the study (Brief title)	Pancreatic cancer project in Matsue
Region	Japan

Condition
Condition	Pancreatic tumor
Classification by specialty	Hepato-biliary-pancreatic medicine Adult
Classification by malignancy	Malignancy
Genomic information	NO

Objectives
Narrative objectives1	We verify the detecting rate of pancreatic cancer by collaboration between general practitioners and general hospitals.
Basic objectives2	Others
Basic objectives -Others	a prospective observational study
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	Detecting rate of pancreatic cancer
Key secondary outcomes

Base
Study type	Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	40 years-old <=
Age-upper limit	120 years-old >
Gender	Male and Female
Key inclusion criteria	Patients with suspected pancreatic cancer from clinical symptoms Patients with multiple pancreatic cancer risk factors Patients that pancreatic cancer can not be denied from the clinical course
Key exclusion criteria	none
Target sample size	300

Research contact person
Name of lead principal investigator	Kazuya Matsumoto
Organization	Medical corporation Irisawa Medical Clinic
Division name	Internal Medicine
Address	285-6, Yawata-cho, Matsue 690-0025
TEL	0852-38-8211
Email	matsumotokazuya@med.tottori-u.ac.jp

Public contact
Name of contact person	Kazuya Matsumoto
Organization	Medical corporation Irisawa Medical Clinic
Division name	Internal Medicine
Address	285-6, Yawata-cho, Matsue 690-0025
TEL	0852-38-8211
Homepage URL
Email	matsumotokazuya@med.tottori-u.ac.jp

Sponsor
Institute	Matsue Medical Association
Institute
Department

Funding Source
Organization	none
Organization
Division
Category of Funding Organization	Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funｄer(s)

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2019 Year 01 Month 06 Day

Progress
Recruitment status	Enrolling by invitation
Date of protocol fixation	2018 Year 04 Month 21 Day
Anticipated trial start date	2018 Year 06 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results	Unpublished
URL releasing results
Results
Other related information	When abdominal ultrasound show main pancreatic ductal dilation, pancreatic cyst, and pancreatic tumor lesion, abnormality is found in blood test, or if pancreatic cancer can not be denied from the clinical course, We perform further examinations at general hospital. The case in which further examinations was performed is registered in the "Matsue pancreatic cancer project".

Management information
Registered date	2019 Year 01 Month 06 Day
Last modified on	2019 Year 01 Month 06 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040401